Versant Venture Management

Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Rayzebio, CRSP, RPTX, GRTS, PASG, and represent 98.62% of Versant Venture Management's stock portfolio.
  • Reduced shares in these 1 stock: Minerva Surgical.
  • Sold out of its position in Minerva Surgical.
  • Versant Venture Management was a net seller of stock by $-275k.
  • Versant Venture Management has $389M in assets under management (AUM), dropping by 106.71%.
  • Central Index Key (CIK): 0001560009

Tip: Access up to 7 years of quarterly data

Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Versant Venture Management

Versant Venture Management holds 7 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
RayzeBio Common Stock 82.5 $321M 5.2M 62.17
 View chart
CRISPR Therapeutics Common Shares (CRSP) 8.0 $31M 499k 62.60
 View chart
Repare Therapeutics Common Stock (RPTX) 5.0 $19M 2.6M 7.30
 View chart
Gritstone Bio Common Stock (GRTS) 1.9 $7.3M 3.6M 2.04
 View chart
Passage Bio Common Stock (PASG) 1.3 $5.0M 5.0M 1.01
 View chart
Adverum Biotechnologies Common Stock 1.0 $3.8M 5.1M 0.75
 View chart
Aligos Therapeutics Common Stock (ALGS) 0.4 $1.5M 2.3M 0.66
 View chart

Past Filings by Versant Venture Management

SEC 13F filings are viewable for Versant Venture Management going back to 2014

View all past filings